Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer
NCT03314649 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2019-05-08
Summary
Our study aims to improve sensitivity and accuracy of detecting abdominal free cancer cells in patients with gastric cancer.
Conditions
Interventions
- OTHER
-
Observational study
Lavage of the Peritoneal Cavity
Sponsors & Collaborators
-
Fudan University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-21
- Primary Completion
- 2019-01-01
- Completion
- 2019-01-01
Countries
- China
Study Locations
More Related Trials
-
MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer
NCT03400657 ·Status: UNKNOWN
-
Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer
NCT05926284 ·Status: RECRUITING
-
Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer
NCT07034742 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Prospective Observational Cohort Study
NCT06493448 ·Status: NOT_YET_RECRUITING
-
Procalcitonin to Predict Infection After Gastrectomy for Gastric Cancer
NCT03780439 ·Status: COMPLETED
-
In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors
NCT06185907 ·Status: COMPLETED
-
Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis
NCT03061162 ·Status: UNKNOWN ·Phase: NA
-
ctDNA for Prediction of Relapse in Gastric Cancer
NCT02887612 ·Status: UNKNOWN
-
Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer
NCT03427684 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Relationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer.
NCT04850729 ·Status: RECRUITING
-
The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer
NCT02425930 ·Status: COMPLETED
-
Next-generation Sequencing in Gastrointestinal Cancer
NCT03476057 ·Status: UNKNOWN
-
the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma
NCT05671393 ·Status: COMPLETED
-
Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy
NCT07260526 ·Status: RECRUITING
-
Effect of Obesity on Surgical Outcomes and Survival for Gastric Cancer
NCT02800005 ·Status: UNKNOWN ·Phase: NA
-
Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis
NCT06943807 ·Status: RECRUITING
-
Multi-center and Multi-modal Deep Learning Study of Gastric Cancer
NCT05001321 ·Status: UNKNOWN
-
Frailty Trajectories and Their Association With Health Outcomes
NCT05793229 ·Status: COMPLETED
-
The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric Cancer
NCT06432205 ·Status: RECRUITING
-
the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer
NCT05235932 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Application of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
NCT06719414 ·Status: RECRUITING
-
DLCS for Predicting Neoadjuvant Chemotherapy Response
NCT05617469 ·Status: UNKNOWN
-
The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer.
NCT02704299 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma
NCT02002416 ·Status: UNKNOWN
-
Bioinformation Therapy for Gastric Cancer
NCT03350477 ·Status: COMPLETED ·Phase: PHASE2/PHASE3